Clinical Trial

An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 12, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-11.
Status change: Not Yet Recruiting → Recruiting 2025-09-07
Trial Details
NCT Number NCT07078682
Lead Sponsor Zenchi, Inc.
Collaborators: Citruslabs
Conditions Uterine Fibroids, Leiomyoma, Menstrual Pain
Enrollment 42 participants
Start Date 2025-08-01
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12